Lynch syndrome and gut immune system study
Part of Cancer, Digestive system, Genetic & congenital, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study looks at how the immune system interacts with the gut lining in people with Lynch syndrome and those without. It may help us better understand how Lynch syndrome affects the body.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18 or older
- Have a confirmed diagnosis of Lynch syndrome with a mutation in MLH1, MSH2, MSH6, PMS2, or EpCAM
- Undergoing a scheduled colonoscopy or surgery as part of your regular care
- If you do not have Lynch syndrome, you may qualify if you have sporadic colorectal lesions or are a healthy control
- Not be pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the genetics and health of people with Lynch syndrome, a condition that raises the risk for certain cancers. Researchers want to learn more about how different genetic changes affect health over time.
This study follows adults with Lynch syndrome (an inherited gene change) using regular questionnaires and tracking health over time. It may help researchers understand how the condition progresses and improve care for people with these gene mutations.
This registry study looks at how many people with colon cancer also have Lynch syndrome, an inherited condition that can affect cancer risk. If you enroll, your care team collects basic information from your diagnosis to better estimate how common it is.
This study is testing whether a simple blood test can safely replace some of the more invasive procedures used to monitor people with Lynch syndrome, a condition that increases the risk of certain cancers (especially colorectal and uterine). If the blood test works as well, it could mean fewer colonoscopies and other invasive tests for those with Lynch syndrome.
This study collects blood and stool samples to see how well they can detect colorectal cancer or advanced growths in people with Lynch syndrome (an inherited colon cancer risk) or suspected Lynch syndrome. It may help find cancer or precancer earlier, which can improve next-step decisions.
This trial tests a preventive vaccine made from your own immune cells (dendritic cells) that is designed to teach your body to fight off Lynch syndrome-related cancers before they develop. It may help stop cancer in people who are at high risk due to their genes.
Hear when a new Lynch Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.